We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cardinal Health Inc | NYSE:CAH | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -3.73 | -3.62% | 99.25 | 102.26 | 98.24 | 101.68 | 3,445,968 | 01:00:00 |
From May 2019 to May 2024
By Chelsey Dulaney
Cardinal Health Inc. (CAH) on Thursday named Michael Kaufmann, who heads the drug distributor's pharmaceutical unit, as the company's chief financial officer.
Mr. Kaufmann will replace Jeffrey Henderson, who is retiring. Mr. Kaufmann, who has led the company's pharmaceutical unit since 2009, will take over as CFO on Nov. 11.
Mr. Henderson, 49, will remain with company until August 2015 to help with the transition.
Mr. Kaufmann will be replaced as chief executive of the pharmaceutical segment by Jon Giacomin, current president of U.S. pharmaceutical distribution.
Write to Chelsey Dulaney at chelsey.dulaney@wsj.com
Access Investor Kit for Cardinal Health, Inc.
Visit http://www.companyspotlight.com/partner?cp_code=A591&isin=US14149Y1082
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Cardinal Health Chart |
1 Month Cardinal Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
